143 related articles for article (PubMed ID: 34010052)
1. Expanding Our Impact in Cervical Cancer Treatment: Novel Immunotherapies, Radiation Innovations, and Consideration of Rare Histologies.
Randall LM; Walker AJ; Jia AY; Miller DT; Zamarin D
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():252-263. PubMed ID: 34010052
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
3. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
Bosch FX; Tsu V; Vorsters A; Van Damme P; Kane MA
Vaccine; 2012 Nov; 30 Suppl 5():F1-11. PubMed ID: 23199951
[TBL] [Abstract][Full Text] [Related]
4. Top advances of the year: Cervical cancer.
Podwika SE; Duska LR
Cancer; 2023 Mar; 129(5):657-663. PubMed ID: 36609769
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus, cancer and vaccination.
Heard I
Curr Opin HIV AIDS; 2011 Jul; 6(4):297-302. PubMed ID: 21519247
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].
Monsonego J
Presse Med; 2007 Apr; 36(4 Pt 2):640-66. PubMed ID: 17350792
[TBL] [Abstract][Full Text] [Related]
8. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer: prevention and treatment.
Denny L
Discov Med; 2012 Aug; 14(75):125-31. PubMed ID: 22935209
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement.
Girda E; Randall LM; Chino F; Monk BJ; Farley JH; O'Cearbhaill RE
Gynecol Oncol; 2023 Dec; 179():115-122. PubMed ID: 37980766
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.
Hung CF; Ma B; Monie A; Tsen SW; Wu TC
Expert Opin Biol Ther; 2008 Apr; 8(4):421-39. PubMed ID: 18352847
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
13. Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study.
Matthijsse SM; Hontelez JA; Naber SK; Rozemeijer K; de Kok IM; Bakker R; van Ballegooijen M; van Rosmalen J; de Vlas SJ
J Infect Dis; 2016 Sep; 214(6):854-61. PubMed ID: 27330051
[TBL] [Abstract][Full Text] [Related]
14. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
Valdespino-Gómez VM
Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
16. Moving forward with human papillomavirus immunotherapies.
Çuburu N; Schiller JT
Hum Vaccin Immunother; 2016 Nov; 12(11):2875-2880. PubMed ID: 27388123
[TBL] [Abstract][Full Text] [Related]
17. Different spectra of therapeutic vaccine development against HPV infections.
Bolhassani A; Mohit E; Rafati S
Hum Vaccin; 2009 Oct; 5(10):671-89. PubMed ID: 19684468
[TBL] [Abstract][Full Text] [Related]
18. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
20. Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.
Kim YT; Serrano B; Lee JK; Lee H; Lee SW; Freeman C; Oh JK; Alemany L; Bosch FX; Bruni L
Papillomavirus Res; 2019 Jun; 7():26-42. PubMed ID: 30599280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]